BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines balance Sheet — Total assets ($M) ($M)
Form 10-Q / 10-K Consolidated Balance Sheets (DB)
Latest, FY2025
8,189
Period ended Dec 31, 2025
Change on a year earlier
+38.3%
5,921 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Balance Sheet — Total assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8,189 | +38.3% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 5,921 | +2.0% | Form 10-K (filed 2025-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 5,805 | -9.0% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 6,379 | -25.3% | Form 10-K (filed 2023-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 8,536 | +52.4% | Form 10-Q (filed 2022-11-09) ↗ |
| FY2020 | Dec 31, 2020 | 5,601 | +247.4% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 1,612 | -28.3% | Form 10-K (filed 2020-03-02) ↗ |
| FY2018 | Dec 31, 2018 | 2,250 | +115.0% | Form 10-K (filed 2019-02-28) ↗ |
| FY2017 | Dec 31, 2017 | 1,047 | +157.9% | Form 10-K (filed 2018-02-28) ↗ |
| FY2016 | Dec 31, 2016 | 406 | +247.4% | Form 10-K (filed 2017-03-22) ↗ |
| FY2015 | Dec 31, 2015 | 117 | – | Form 10-Q (filed 2016-05-12) ↗ |
Breakdown
What makes up balance sheet — total assets ($m)
- Cash and cash equivalents ($M)4,548 · FY2025
- Accounts receivable, net ($M)865 · FY2025
- Inventories, net ($M)608 · FY2025
- Total current assets ($M)6,234 · FY2025
- Property, plant and equipment, net ($M)1,642 · FY2025
- Intangible assets, net ($M)62.7 · FY2025
- Accounts payable ($M)479 · FY2025
- Total current liabilities ($M)1,829 · FY2025
- Long-term bank loans ($M)962 · FY2025
- Total liabilities ($M)3,827 · FY2025
- Accumulated deficit ($M)-8,320 · FY2025
- Total shareholders' equity ($M)4,361 · FY2025
Cite this data
StockData. (2026). BeOne Medicines Balance Sheet — Total assets ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_balance_sheet
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.